Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Mar 2021
Historique:
received: 24 02 2021
revised: 23 03 2021
accepted: 25 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 9 7 2021
Statut: epublish

Résumé

A library of novel 4-{[(benzyloxy)carbonyl]amino}-2-hydroxybenzoic acid amides was designed and synthesized in order to provide potential acetyl- and butyrylcholinesterase (AChE/BChE) inhibitors; the in vitro inhibitory profile and selectivity index were specified. Benzyl (3-hydroxy-4-{[2-(trifluoromethoxy)phenyl]carbamoyl}phenyl)carbamate was the best AChE inhibitor with the inhibitory concentration of IC

Identifiants

pubmed: 33810550
pii: ijms22073444
doi: 10.3390/ijms22073444
pmc: PMC8037530
pii:
doi:

Substances chimiques

Carbamates 0
Cholinesterase Inhibitors 0
Ligands 0
Solvents 0
Aminosalicylic Acid 5B2658E0N2
Acetylcholinesterase EC 3.1.1.7
Butyrylcholinesterase EC 3.1.1.8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Molecules. 2012 Aug 24;17(9):10142-58
pubmed: 22922284
SAR QSAR Environ Res. 2017 Jun;28(6):427-449
pubmed: 28573881
J Mol Graph. 1995 Apr;13(2):98-108
pubmed: 7619791
Curr Opin Chem Biol. 2004 Jun;8(3):255-63
pubmed: 15183323
Molecules. 2018 Aug 14;23(8):
pubmed: 30110946
J Comput Chem. 2008 Jul 15;29(9):1429-39
pubmed: 18270964
Nucleic Acids Res. 2015 Jul 1;43(W1):W443-7
pubmed: 25873628
Methods Mol Biol. 2013;930:3-27
pubmed: 23086835
Nat Rev Drug Discov. 2012 Apr 30;11(5):355-65
pubmed: 22543468
J Chem Inf Model. 2007 Jul-Aug;47(4):1469-80
pubmed: 17567123
J Med Chem. 2007 Nov 29;50(24):6080-94
pubmed: 17967002
Curr Top Med Chem. 2017;17(27):3000-3016
pubmed: 28714419
Int J Mol Sci. 2019 Oct 21;20(20):
pubmed: 31640137
Future Med Chem. 2009 Jun;1(3):451-66
pubmed: 21426126
Molecules. 2017 Nov 14;22(11):
pubmed: 29135926
J Chem Inf Model. 2008 Mar;48(3):646-58
pubmed: 18303878
Molecules. 2011 Mar 14;16(3):2414-30
pubmed: 21403599
Chemosphere. 2016 Nov;162:189-98
pubmed: 27497349
Molecules. 2018 Aug 06;23(8):
pubmed: 30082652
J Enzyme Inhib Med Chem. 2017 Dec;32(1):572-587
pubmed: 28133981
Nat Rev Drug Discov. 2003 Mar;2(3):192-204
pubmed: 12612645
Drug Discov Today. 2009 Jul;14(13-14):698-705
pubmed: 19410012
Curr Top Med Chem. 2009;9(9):755-70
pubmed: 19754393
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Biochem Pharmacol. 1961 Jul;7:88-95
pubmed: 13726518
Clin Interv Aging. 2017 Apr 18;12:697-707
pubmed: 28458525
SAR QSAR Environ Res. 2018 Oct;29(10):801-821
pubmed: 30230355
Molecules. 2018 Dec 11;23(12):
pubmed: 30544967
Bioorg Chem. 2020 Sep;102:104060
pubmed: 32663668
Molecules. 2011 Sep 05;16(9):7565-82
pubmed: 21894089
Anal Biochem. 2007 Nov 15;370(2):223-7
pubmed: 17716616
Int J Mol Sci. 2019 Oct 29;20(21):
pubmed: 31671776
J Med Chem. 2014 Jun 26;57(12):4977-5010
pubmed: 24351051
Trends Pharmacol Sci. 2015 Feb;36(2):78-95
pubmed: 25543280
J Chem Inf Model. 2006 Nov-Dec;46(6):2310-8
pubmed: 17125174
J Chem Inf Model. 2008 Aug;48(8):1716-28
pubmed: 18686944
J Struct Biol. 2007 Mar;157(3):606-15
pubmed: 17029846
Trends Pharmacol Sci. 2006 Mar;27(3):149-57
pubmed: 16483674
Z Naturforsch C J Biosci. 2004 Mar-Apr;59(3-4):293-6
pubmed: 15241943
J Alzheimers Dis. 2016 Dec 6;55(3):1285-1294
pubmed: 27858711
Biophys J. 2015 Apr 21;108(8):1843-7
pubmed: 25902423
J Chem Inf Comput Sci. 2003 May-Jun;43(3):819-28
pubmed: 12767139
Bioorg Med Chem. 2013 Apr 1;21(7):1735-48
pubmed: 23462716
Int J Mol Sci. 2019 Mar 27;20(7):
pubmed: 30934674

Auteurs

Jiri Kos (J)

Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic.

Violetta Kozik (V)

Department of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland.

Dominika Pindjakova (D)

Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia.

Timotej Jankech (T)

Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia.
NT-LAB o.z., Teplicka 35, 92101 Piestany, Slovakia.

Adam Smolinski (A)

GiG Research Institute, Pl. Gwarkow 1, 40166 Katowice, Poland.

Sarka Stepankova (S)

Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 53210 Pardubice, Czech Republic.

Jan Hosek (J)

Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.

Michal Oravec (M)

Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic.

Josef Jampilek (J)

Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacky University, Slechtitelu 27, 78371 Olomouc, Czech Republic.
Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia.

Andrzej Bak (A)

Department of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH